Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Why Did Shield Therapeutics Plc (LSE:STX) Shares Fall Today Despite Its Commercial Growth Ambitions?

Shield Therapeutics Plc (STX) is a UK-listed specialty pharmaceutical company focused on the treatment of iron deficiency, best known for its oral iron therapy marketed under different brand names across regions. The company sits at an interesting stage: past the early development risk, but …

Divya Sood | 03 July 2026

What Factors Are Behind the Fall in PureTech Health PLC (LSE:PRTC) Shares Today?

PureTech Health PLC (PRTC) is a biotherapeutics company that builds and advances a portfolio of founded entities, each developing therapies across a range of disease areas. This portfolio model differentiates PureTech from single-asset biotech companies, spreading both risk and opportunity across multiple pipelines.

Divya Sood | 03 July 2026

What Is Driving The Decline In Renalytix Shares?

Renalytix plc is a healthcare diagnostics company focused on developing artificial intelligence-enabled solutions for kidney disease assessment and early detection. The company aims to improve clinical outcomes through advanced diagnostic testing and predictive analytics.

Divya Sood | 03 July 2026

AGY – Allergy Therapeutics Rises: Is the Market Waking Up to This Healthcare Name?

Healthcare investors had a name to discuss on Thursday 2 July 2026 asAllergy Therapeutics (LSE:AGY)advanced 9.84 per cent to close at 6.92 pence, earning the specialty pharmaceutical group a spot among the day's top gaining UK stocks. For a company with a market capitalisation …

Ankur Sharma | 03 July 2026

What Is Driving The Decline In Craneware Shares?

Craneware plc is a healthcare software company that provides revenue cycle management, analytics, and financial performance solutions to healthcare providers, particularly hospitals in the United States. The company benefits from long-term demand for digital healthcare solutions and operational efficiency tools.

Divya Sood | 03 July 2026

Can LSE:CLBX - CelLBxHealth plc Benefit from the Global Expansion of Precision Medicine and Liquid Biopsy Technologies?

CelLBxHealth plc has become one of the most actively discussed AIM-listed healthcare companies as investors evaluate whether its precision oncology platform can translate scientific innovation into commercial growth. The company's focus on circulating tumour cell (CTC) technology, cancer diagnostics and research collaborations places it …

Ankur Sharma | 02 July 2026

Can LSE:CNSL - Cambridge Nutritional Sciences PLC Benefit from the Growing Global Demand for Personalised Healthcare and Diagnostic Testing?

• Cambridge Nutritional Sciences remains one of the AIM market's specialist healthcare diagnostics companies focused on nutritional and food intolerance testing.

Ankur Sharma | 02 July 2026

Is LSE:SEED - Seed Innovations Limited Positioned for Long-Term Growth Through Its Diversified Healthcare Portfolio?

• Seed Innovations remains one of the AIM market's specialist healthcare investment companies with exposure to biotechnology, medical technology and life sciences businesses.

Ankur Sharma | 02 July 2026

Is LSE:4BB - 4basebio PLC Becoming One of the Most Watched FTSE AIM Biotechnology Stocks as DNA Manufacturing Demand Accelerates?

• 4basebio remains one of the AIM market's leading synthetic DNA technology companies serving the rapidly expanding cell and gene therapy industry.

Ankur Sharma | 02 July 2026

Is LSE:BVXP - Bioventix Plc Positioned for Long-Term Growth Through Its Premium Monoclonal Antibody Business?

• Bioventix remains one of the UK's highest-quality specialist life sciences businesses with a global reputation for developing high-affinity monoclonal antibodies used in diagnostic testing.

Ankur Sharma | 02 July 2026
Support

Hi! How can we help you today?

Loading…